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Objective: To assess DWI and ADC value in characterization of orbital masses (differentiation of benign,
inflammatory and malignant orbital masses).
Patients & methods: Cross-sectional study included 38 patients, and diagnosed histopathologically, clin-
ically and radiologically 26 with benign and inflammatory masses and 12 with malignant masses. Their
ages ranged from 15 to 63 years. They were examined using 1.5 T MR machine.
Results: There was a significant difference in ADC value of malignant and benign orbital masses. Malignant
masses have a lower ADC values and restricted diffusion, compared with benign masses. Using
0.93  103 mm2/s as a cutoff value, in differentiating malignant from benign lesions, resulted in a total
of 80% sensitivity, 83.3% specificity and 82% accuracy. Lesions with ADC values less than 0.87 
103 mm2/s, had 90% likely to be of malignant nature. Lesions with ADC greater than 1.1  103 mm2/s,
had 90% likely to be of benign nature. In between these two values, lesions are indeterminate.
Conclusion: Diffusionweighted imagingwith ADC value, can help in differentiatingmalignant from benign
orbital masses. Malignant orbital masses have a significant lower ADC value than benign masses. We can
use ADC cutoff value between malignant and benign masses.
 2016 The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).1. Introduction distinguish among different kinds of tissues and can give a valuableThe orbit is affected by different types of lesions (inflammatory,
benign tumors, malignant primary tumors, and metastases) [1].
Some lesions can be diagnosed easily depending on the imaging
findings such as typical location and enhancement pattern, but
sometimes their characterization as an inflammatory, benign or
malignant orbital masses is still difficult, so we need additional
information to help in the proper diagnosis and greatly facilitate
clinical management planning [1–3].
Multi-slice computed tomography and magnetic resonance
imagingwere used to localize orbital tumors and to determine their
extent. However, malignant and benign orbital lesions may have
non-specific and overlapping imaging findings, and as a result,
tumors may be misdiagnosed in unexpected rare tumor entities
[2,3].
Diffusion-weighted imaging (DWI) is specific promising MR
sequence that uses the diffusion of moving water protons toinformation in the assessment of pathological tissues and help to
distinguish malignant from benign lesions [4–6].
Diffusion-weighted MR imaging has been used for differentia-
tion between benign and malignant thyroid nodules, cervical
lymph nodes, and parotid masses [7].
Many earlier studies suggested that DWI and apparent diffusion
coefficient (ADC) measurements have a role for the prediction of
malignancy in orbital tumors, in differentiation of orbital lym-
phoma from pseudotumors, and in assessment of orbital cellulitis,
identifying orbital abscesses, and identifying optic nerve lesions
and infarct [1,6–8].
The aim of the study was to evaluate the role of DWI and mea-
surement of ADC values in characterization of different orbital
masses.
2. Patients & methods
2.1. Patients
This study was compliant with our institution committee ethics
with a written consent taken from all patients. It was carried out
Table 1
All patients’ demographic data.
Patients
N (38)
AGE Mean ± (SD) 13–65 (45)
Sex Male 22 (58%)
Female 16 (42%)
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from 13 years to 65 years with a mean age of 45 years (Table 1),
from December 2012 till June 2015. All the patients were referred
from ophthalmology department and outpatient clinics with orbi-
tal lesions to radiology department.
All patients were subjected to
(1) Conventional MRI:Please All the cases examined by MRI using 1.5 T superconduct-
ing MR imager (Philips-achieva). All cases were examined
in a supine position with a standard circularly polarized
head coil.
 A scout sagittal T1-weighted view was obtained to verify
the precise position of the patient and to act as a localizer
for subsequent slices, and then multiple pulse sequences
were used in multiple planes. T1WI and T2WI with fat
suppression were obtained. DWI was done in axial plane
for all cases. After intravenous administration of contrast
material either Omniscan or Magnevist [Gadolinium
Diethylene Triamine Penta acetic acid (‘‘Gd-DTPA”)]
0.1 mmol/kg, contrast enhanced T1 weighted spin echo
with fat suppression sequence was obtained in axial,
coronal and sagittal planes. Examination was done by
the following parameters: TR/TE of 350–370/10–12 ms
for T1WI and TR/TE of 2800–3500/70–90 ms for T2WI,
with a field of view (FOV) of 20  22 cm, Slice thickness
of 4 mm with 1–2 mm interval, and matrix of 128  128.(2) Diffusion-weighted MRI:
All cases were evaluated by DWI in axial planes with ADC map.
Single shot echo-planar diffusion-weighted imaging sequence was
done. Imaging parameters of DWI were as follows: repetition time
(TR)/echo time (TE) = 8000/68 ms; the time interval between
leading edges of diffusion gradients (D)/pulse gradient duration
(d) = 39/32 ms; slice thickness/gap, 4 mm/1–2 mm; matrix
128  128; field of view (FOV), 20  22 cm; number of excitations
(NEX) = 1. DWI was acquired with a diffusion-weighted factor,
using b value of 0, 500 and 1000 s/mm2. The data acquisition time
for DWI was 1.33 min.2.2. Post-processing
DWI data were transferred to the workstation and ADC values
were generated for all images.2.3. Image analysis
Signal characteristics on DWI and ADC maps were described as
a hyperintense for bright or similar signal intensity lesions and as a
hypointense for those with low signal intensity compared to nor-
mal cortical gray matter.
To calculate the ADC values, the sizes of the regions of interest
were adjusted according to the lesion size. Two or more regions of
interest were placed in larger lesions and their mean value was
used to increase the reliability of the calculation. Care was takencite this article in press as: Hemat EM. . Egypt J Radiol Nucl Med (2016to avoid the edges of the lesions to exclude the effect of partial vol-
ume averaging.
2.4. Statistical analysis
Student t test and the mean standard deviation (±SD) of ADC
values were used to compare between benign and malignant cases.
The statistical analysis of data was done using the Excel and the
SPSS programs (Statistical Package for the Social Science)
version 18.
Fisher exact test was performed to compare the signal charac-
teristics of DWI images and ADC maps between benign and malig-
nant lesions.
P value > 0.05 was non-significant.
P value < 0.05 was significant.
P value < 0.01 was highly significant.
3. Results
The orbital lesions in this study were classified into two groups:
Group I: Malignant tumors, 13 cases, including 6 cases of lym-
phoma (Fig. 1), 4 cases of adenocarcinoma, 2 cases of metastases,
and one case of optic nerve glioma (Fig. 2).
Group II: Benign lesions, 25 cases, include benign tumors and
other inflammatory lesions. Benign lesions in our study are 8 cases
of idiopathic orbital inflammatory lesion (pseudotumors) (Fig. 3), 4
cases of meningioma (Fig. 4), 4 cases of hemangioma (Fig. 5), 2
cases of lacrimal gland pleomorphic adenoma, 3 cases of lacrimal
gland adenitis, and 4 cases of orbital infections. Pathological exam-
ination was done for 22 patients to reach the final diagnosis. For
the remaining 16 patients, the final diagnosis was expected
without biopsy from clinical course of the disease, patient dramatic
response to antibiotic, anti-inflammatory, and corticosteroid treat-
ment and through typical imaging appearances.
The mean ± SD for ADC values in malignant and benign orbital
masses was 0.77 ± 0.22  103 and 1.41 ± 0.38  103 mm2/s,
respectively revealing a significant difference (p-value6 0.001)
(Table 2).
The lowest ADC values were in the cases of lymphoma, and
other malignant masses such as adenocarcinoma, and metastasis.
The highest ADC values were in the cases of lacrimal adenitis,
idiopathic inflammatory lesions, and benign tumors such as lacri-
mal gland pleomorphic adenoma.
Receiver operating characteristic (ROC) curve (Fig. 6) analysis
was used to identify optimal cutoff values of ADC with maximum
sensitivity and specificity for diagnosis of malignancy.
Area under curve (AUC) was also calculated. The optimal cutoff
point was established at point of maximum accuracy.
Using the apparent diffusion coefficient value of
0.93  103 mm2/s as a cutoff value for orbital lesions characteri-
zation, resulted in sensitivity of 80%, a specificity of 83.3%, and
an accuracy of 82%. Using higher or lower ADC values was on the
expense of either sensitivity or specificity (Table 3).
Our results show that some lesions have limited range of ADC
values as seen in lymphoma which show restricted diffusion. .
Other highly malignant lesions such as adenocarcinoma have
restricted diffusion.
Most cases of inflammatory lesions have higher ADC value
>1  103 mm2/s.
An ADC threshold of 0.88  103 mm2/s can differentiate
between them with very high sensitivity and specificity.
The mean ADC value of lymphoma (0.55 ± 0.1  103 mm2/s)
was significantly different (P = 0.001) from both primary
adenocarcinoma (0.91 ± 0.12  103 mm2/s) and metastases
(1.04 ± 0.83  103 mm2/s).), http://dx.doi.org/10.1016/j.ejrnm.2016.10.003
Fig. 1. (A–F): A non-Hodgkin lymphoma male patient presented by right side proptosis. Diffuse extraconal lesion involving the right lacrimal gland and extending posteriorly
displacing the lateral rectus muscle medially. (a) Axial T1WI and (b) axial T2WI show hypointense signals, (c and d) axial and coronal post-contrast T1WI shows mild
enhancement, (e) DWI shows hyperintense signal, and (f) ADC map shows hypointense signal with ADC 0.64  103 mm2/s.
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Many earlier studies suggested that diffusion weighted imaging
(DWI) with apparent diffusion coefficient (ADC) measurements can
reveal benignancy or malignancy of brain tumors, head and neck
masses, including the orbits [1,6,8], and can reveal the viable parts
within a tumor [9]. In this study we discussed the role of DWI withPlease cite this article in press as: Hemat EM. . Egypt J Radiol Nucl Med (2016ADC map as an additional tool, to conventional MRI in contrast to
the evaluation of different types of multiple malignant tumors and
benign lesions of the orbit.
We found that a mean ADC value for malignant masses was
0.77 ± 0.22  103 mm2/s and for benign lesions was
1.51 ± 0.39  103 mm2/s. There was a significant difference
between the signal intensity in ADC map as well as the ADC value), http://dx.doi.org/10.1016/j.ejrnm.2016.10.003
Fig. 2. (A–E): An optic nerve glioma young patient presented with visual disturbances and headache. Right intraorbital retrobulbar small expanding mass in right optic nerve.
(a) Axial T1WI shows iso- to hypointense signal, (b & c) axial fat saturated T2WIand axial STIR show hyperintense signal, (d) post-contrast T1WI shows mild homogenous
enhancement, and (e) ADC map shows mild hypointense signal with ADC 1.124  103 mm2/s.
4 E.M. Hemat / The Egyptian Journal of Radiology and Nuclear Medicine xxx (2016) xxx–xxxbetween benign and malignant masses (P < 0.001), but with some
overlaps.
Malignant masses have significantly lower ADC value than
benign lesions. This was in agreement with Abdel-Razek et al.
[7], Serifoglu et al. [10], Fatima et al. [11], and Sepahdari et al. [12].
Sepahdari et al. [13] reported that the mean ADC value for
malignant masses was 1.02 ± 0.42  103 mm2/s, and forPlease cite this article in press as: Hemat EM. . Egypt J Radiol Nucl Med (2016benign lesions it was 1.36 ± 0.41  103 mm2/s. Abdel Razek et al.
[7], reported that the mean ADC value for malignant
masses was 0.8 ± 0.34  103 mm2/s, and for benign lesions
it was 1.53 ± 0.35  103 mm2/s. Fatima et al. [11], reported that
the mean ADC value for malignant masses was 0.77 ±
0.38  103 mm2/s, and for benign lesions it was
1.23 ± 0.42  103 mm2/s.), http://dx.doi.org/10.1016/j.ejrnm.2016.10.003
Fig. 3. (A–F): An idiopathic inflammatory orbital lesion (pseudotumor) female patient presented by left side proptosis. Periorbital and retrobulbar ill defined soft tissue
thickening and stranding of the retro-orbital fat with mildly thickened lateral rectus muscle. (a) Axial T1WI shows hypointense signal, (b & c) axial and coronal T2WI shows
hypointense signal, (d) axial post-contrast T1WI shows mild enhancement, (e) DWI shows hypointense signal, (f) ADC map shows hyperintense signal with ADC
1.11  103 mm2/s.
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have deformed, peculiar and enlarged nuclei with
hypercellularity and these histological characteristics reduce
the available spaces for water proton diffusion in bothPlease cite this article in press as: Hemat EM. . Egypt J Radiol Nucl Med (2016intracellular and extra cellular spaces and so result in decreased
ADC values.
When ADC value of 0.93  103 mm2/s was used as a cutoff
value for differentiation of malignant tumors from benign lesions,), http://dx.doi.org/10.1016/j.ejrnm.2016.10.003
Fig. 4. (A–F): An optic nerve meningioma female patient presented by right side proptosis. Right intraorbital retrobulbar abnormal signal intensity mass extending to the
orbital apex surrounding the optic nerve with tram-track configuration. (a) Axial T1WI shows iso to hypointense signal, (b & c) axial and sagittal T2WI shows isointense
signal, (d) sagittal post-contrast T1WI shows mild homogenous enhancement, (e) DWI shows isointense signal, and (f) ADC map shows hypointense signal with ADC
0.83  103 mm2/s.
6 E.M. Hemat / The Egyptian Journal of Radiology and Nuclear Medicine xxx (2016) xxx–xxxthe sensitivity was 80%, the specificity was 83.3% and the accuracy
was 82%.
There were a variable cutoff values used in previous study and
each one yields different sensitivity, specificity, and accuracy. For
example Abdel-Razek et al. [7], found that by usingPlease cite this article in press as: Hemat EM. . Egypt J Radiol Nucl Med (20161.15  103 mm2/s as cutoff value, the best result was obtained
with sensitivity of 95%, specificity of 91% and accuracy of 93%.
Sepahdari et al., [13] reported that a cutoff value
1.0  103 mm2/s was 63% sensitive, 84% specific and 77% accu-
rate, however when using more stringent cutoff value of), http://dx.doi.org/10.1016/j.ejrnm.2016.10.003
Fig. 5. (A–F): A cavernous hemangioma female patient presented by left side proptosis. Left intraorbital retrobulbar intraconal abnormal signal intensity ovoid shape mass
displacing the optic nerve and both medial and lateral recti muscles. (a) Axial T1WI shows hypointense signal, (b) axial T2WI shows hyperintense signal, (c and d) axial and
sagittal post-contrast T1WI shows mild homogenous enhancement, (e) DWI shows isointense signal, and (f) ADC map shows isointense signal with ADC about
1.02  103 mm2/s.
E.M. Hemat / The Egyptian Journal of Radiology and Nuclear Medicine xxx (2016) xxx–xxx 70.9  103 mm2/s, it was only 44% sensitive, but was 97% specific
for prediction of malignancy.
Fatima et al. [11], used lower ADC value as cutoff value
(0.84  103 mm2/s) and this resulted in 83.33% sensitivity and
85.71% specificity for distinguishing malignant from benign
lesions.Please cite this article in press as: Hemat EM. . Egypt J Radiol Nucl Med (2016Roshdy et al. [14], noted that there was an overlap of benign
and malignant lesions, but did not calculate a threshold ADC value.
Because of these different results and different cutoff values
mentioned in these studies, no single ADC threshold model can
be used and considered sensitive and specific for differentiating
malignant from benign masses. Two-threshold model was used), http://dx.doi.org/10.1016/j.ejrnm.2016.10.003
Table 2
Minimum, maximum, and mean standard deviation ADC values in malignant and benign orbital masses.
Number ADC (minimum)
103 mm2/s
ADC (maximum)
103 mm2/s
ADC (mean &SD)
103 mm2/s
Malignant lesions 13 0.38 1.34 0.77 ± 0.22
Lymphoma 6 0.38 0.70 0.55 ± 0.10
Adenocarcinoma 4 0.78 1.17 0.91 ± 0.12
Metastases 2 0.85 1.34 1.04 ± 0.83
Optic nerve glioma 1 0.90 1.27 1.09 ± 0.18
Benign lesions 25 0.8 2.2 1.41 ± 0.38
Pseudotumor (IOI lesion) 8 1.10 2.2 1.57 ± 0.38
Hemangioma (vascular lesions) 4 1.24 1.60 1.44 ± 0.12
Meningioma 4 0.80 1.13 0.96 ± 0.15
Lacrimal gland adenoma 2 1.68 1.72 1.70 ± 0.03
Lacrimal gland adenitis 3 1.6 1.96 1.78 ± 0.16
Infections 4 0.8 1.89 1.18 ± 0.43
Fig. 6. Receiver operating characteristic (ROC) curve analysis of ADC for distin-
guishing malignant from benign masses and calculating cutoff value for
differentiation.
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map. Orbital masses were categorized into three groups: the 1st
group: likely malignant, and these lesions have >90% probability
of being malignant depending on ADC value less than
0.87  103 mm2/s; the 2nd group: likely benign, and these lesions
have >90% probability of being benign depending on ADC value
more than 1.1  103 mm2/s; and the last group: indeterminate
masses, and these lesions have ADC value between 0.87 and
1.1  103 mm2/s.
Similar method was used by Sepahdari et al. [12], who also pro-
posed 2-threshold model for characterization of orbital masses andTable 3
Orbital lesions sensitivity, specificity, positive predictive and negative predictive values an
ADC threshold value 103 mm2/s Sensitivity (95% CI) Specificity (95% CI)
60.87 60% 90%
60.93 80% 83.3%
61.1 90% 70%
CI (confidence interval).
AUC (area under curve).
Please cite this article in press as: Hemat EM. . Egypt J Radiol Nucl Med (2016classified them into three groups, the group likely malignant has
ADC value less than 0.93  103 mm2/s, and the group likely
benign has ADC value more than 1.35  103 mm2/s, while inde-
terminate group has ADC value between 0.93 and
1.35  103 mm2/s.
Our study revealed a significant difference between the signal
intensity in ADC map as well as the ADC value in lymphoma and
idiopathic orbital inflammatory lesions (P < 0.001). Lymphoma
mean ADC value was 0.55 ± 0.1  103 mm2/s (ranging from 0.38
to 0.7  103 mm2/s), and for idiopathic orbital inflammatory
lesions it was 1.57 ± 0.38  103 mm2/s (ranging from 1.1 to
2.2  103 mm2/s). No overlap was found between their ADC val-
ues and a cutoff value of 0.88 was highly sensitive and specific
for differentiation. This was in agreement with Sepahdari et al.
[12], Kapur et al. [4], Politi et al. [5], Abdel-Razek et al. [7], Ragheb
et al. [15], Tailor et al. [16], Grech et al. [17], Thoeny et al. [18], De
Figueiredo et al. [19], and Fatima et al. [11].
In our study we also found that a mean ADC value of lymphoma
(0.55 ± 0.1  103 mm2/s) was significantly different (P = 0.001)
from both primary adenocarcinoma (0.91 ± 0.12  103 mm2/s)
and metastases (1.04 ± 0.83  103 mm2/s). This is due the fact
that lymphoma has high cellularity which even exceeds the high
cellularity of other malignant tumors.
This was in agreement with Abdel Razek et al. [7], who found a
significant difference in the ADC value of lymphoma
(0.67 ± 0.08  103 mm2/s) and metastasis (0.98 ± 0.06 
103 mm2/s), P value = 0.03.
Our study showed no significant difference between the mean
ADC value of optic nerve glioma (1.09 ± 0.18  103 mm2/s) and
optic pathway meningioma (0.96 ± 0.15  103 mm2/s) (P = 0.56).
Marked overlap is seen between ADC values for cases of optic
nerve glioma and meningioma.
This was in disagreement with Fatima et al. [11], and Tailor
et al. [16], who found a significant ADC value differences between
optic nerve glioma (1.31 ± 0.09  103 mm2/s) and meningioma
(0.9 ± 0.08 103 mm2/s) and P value was 0.03, because optic nerve
gliomas are low grade tumors classified histologically as pilocystic
astrocytomas, which have higher ADC values. However they also
mentioned that meningiomas have high variability in cellularityd accuracy of different ADC threshold values.
PPV (95% CI) NPV (95% CI) Accuracy (95% CI) AUC (95% CI)
80% 77.1% 78% 0.883
76.2% 86.2% 82%
66.7% 91.3% 78%
), http://dx.doi.org/10.1016/j.ejrnm.2016.10.003
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ADC may not be easy in all cases. Although there was no overlap
between ADC values of lymphoma and meningioma in our study,
ADC is not reliable tool for differentiation as the maximum value
of ADC in cases of lymphoma is 0.7  103 mm2/s which is near
the lower limit of meningioma range (0.8  103 mm2/s). This
was also due to variability in the cellularity of meningioma. This
was in agreement with Sepahdari et al. [12].
There may be some bias from selection of the region of interest
to calculate the ADC value. We tried to overcome this problem in
large or heterogenous masses by selecting multiple regions of
interest and then calculate the average of them.
5. Conclusion
It was concluded that malignant orbital masses had a significant
lower ADC value than benign masses. Using ADC value of
0.93  103 mm2/s as a cutoff value for differentiation of malig-
nant from benign orbital lesions, the sensitivity was 80%, the speci-
ficity was 83.3% and the accuracy was 82%. DWI-MR with ADC
value is a valuable, available and non-invasive imaging modality
for characterization of different orbital masses.
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